SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $151,658,000 | +23.7% | 1,554,979 | +17.7% | 0.01% | +11.1% |
| Q4 2014 | $122,569,000 | +37.7% | 1,320,921 | +2.1% | 0.01% | +28.6% |
| Q3 2014 | $89,002,000 | -31.5% | 1,294,021 | +4.3% | 0.01% | -30.0% |
| Q2 2014 | $129,992,000 | +47.3% | 1,240,381 | +16.6% | 0.01% | +42.9% |
| Q1 2014 | $88,251,000 | +42.7% | 1,063,652 | +11.3% | 0.01% | +40.0% |
| Q4 2013 | $61,849,000 | +12.6% | 955,628 | +10.1% | 0.01% | 0.0% |
| Q3 2013 | $54,927,000 | +99.3% | 867,605 | +32.2% | 0.01% | +66.7% |
| Q2 2013 | $27,562,000 | – | 656,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,223,182 | $387,189,000 | 7.66% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 78,486 | $3,295,000 | 0.56% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,485,288 | $104,382,000 | 0.46% |
| HARVEY CAPITAL MANAGEMENT INC | 34,800 | $1,460,000 | 0.45% |
| EMERALD ADVISERS, LLC | 148,232 | $6,223,000 | 0.38% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 148,411 | $6,233,000 | 0.27% |
| ArrowMark Colorado Holdings LLC | 15,500 | $651,000 | 0.18% |
| CR Intrinsic Investors, LLC | 118,161 | $4,963,000 | 0.17% |
| BB BIOTECH AG | 53,549 | $2,248,000 | 0.16% |
| TURNER INVESTMENTS LLC | 209,744 | $8,806,000 | 0.12% |